Bristol-Myers Squibb selects CEO Giovanni Caforio as new chairman

Bristol-Myers Squibb announced Wednesday that CEO Giovanni Caforio will become chairman affective May 2 next year. The company noted that Caforio, who became chief executive in 2015, will succeed current chairman Lamberto Andreotti, who has announced plans to retire.

"It is an honour to have the opportunity to build on the strong foundation established by [Andreotti]," Caforio remarked, adding "working with the talented leaders and employees of this company, I look forward to further advancing our BioPharma strategy, and delivering transformational medicines that make a difference in the lives of patients around the world."

Caforio, who succeeded Andreotti as CEO, previously served as Bristol-Myers Squibb's chief operating officer and chief commercial officer, joining the board of directors in 2014.

"Since becoming CEO last year, [Caforio] has demonstrated strong leadership and a commitment to the company's patient-focused mission and culture of integrity and ethics," commented Togo West, Jr., the board's lead independent director, adding "[Caforio's] depth of experience, knowledge and deep understanding of the industry make him the right person for the chairmanship."

December 21st, 2016

By: Joe Barber

Source: https://www.firstwordpharma.com/